Integrated Therapeutic Antibody Services - ProteoGenix Inc

One partner for your end-to-end therapeutic antibody development  project

Please visit our website for more information on this topic.

Maximize your chances of reaching the clinic with one partner offering an end-to-end therapeutic antibody services paired with customized strategies: from complex antigen design service to antibody production.

Turn your antibody program into results with dedicated expert support

You get dedicated support from PhD-level experts who stay focused on your project’s success. This integrated support keeps your therapeutic antibody development tightly aligned with your goals at every step. Every strategy is fully tailored to your constraints, so your custom antibody development is built to fit your reality. Our experienced project managers are used to running complex antibody programs, including challenging targets and advanced formats.
It helps you move faster through key milestones and shorten timelines and it de-risks your program by keeping the focus on the most promising candidates.

Contact our PhD-level experts

AlpVHHs® contains other products and information you need, so please check it out.

Therapeutic antibody services with risk control included

Milestone-based delivery keeps the program on track with clear, validated outcomes at each step. You de-risk your monoclonal antibody program through clear decision gates and validated deliverables.

IP Free: your innovation stays your property

You retain full ownership of the antibody, sequences, and project data generated throughout the program. All deliverables are royalty-free, with no downstream claims or licensing constraints. You can move forward to development, manufacturing, or partnering without restrictions.

Contact us

License Opportunities

Immune Biosolutions also develops its own therapeutic antibodies. We focus on targets with unmet needs for immuno-oncology and infectious diseases. The company is interested in building strategic partnerships with biotech and pharmaceutical companies to bring our pipeline assets to a successful development. Contact us if you are interested in in-licensing opportunities!